StockWatch
·
DODLA DAIRY LTD · QQ1 FY-2027 · THE CALL

Revenue growth masks 35% PAT collapse; margin recovery depends on price-pass timing

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsDODLADodla Dairy Ltd02 Aug 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Hit Q1 revenue target (19% vs 19% delivered), but missed EBITDA margin guide (5.4% actual vs 7-8% target). Margin miss is material (280 bps). Price hikes initiated July 15 were reactive, not proactive.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong volume and revenue growth (+19% YoY, record ₹1,198 Cr) masks a structural margin collapse: PAT crashed 35% YoY to ₹41 Cr, EBITDA margin fell 280 bps to 5.4% vs 8.2% prior year. Management attributes this to temporary procurement inflation and gradual pricing—but the real issue is execution lag: procurement costs rose ₹3.9/liter YoY while milk prices only rose ₹2.2/liter, a 44% shortfall. Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).

₹1198 Cr

Revenue · +19% YoY

₹41 Cr

Reported PAT · −35.4% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Margin pressure is cyclical, expect recovery Q2 onwards

OVERSTATED

EBITDA margin collapsed to 5.4% vs 8.2% a year ago; 280 bps decline. Q1 YoY PAT fell 35.4%

Prices not fully passed, will gradually pass to consumers in forthcoming quarters

MISS

Milk sales price only rose ₹2.2/liter YoY despite ₹3.9/liter procurement cost hike. Pricing lagged 44% of cost inflation

Highest-ever quarterly revenue of ₹1,198 crores, 19% YoY

MET

Delivered ₹1,197.9 Cr, 19.0% YoY growth confirmed

India standalone milk procurement grew (ex-OSAM only 3%)

MET

Analysts pressed hard: India DDL only 3% volume growth vs prior 8-9%. Africa & Maharashtra drove blended 13% growth

VAP highest-ever sales of ₹415 crores, 17.6% growth; ex-bulk 40.6% growth

MET

Confirmed ₹414.7 crores VAP ex-bulk, 40.6% LTL growth supported

Africa delivered ₹154 crores revenue, 45.6% growth, EBITDA ₹24 crores up 74%

MET

Call confirms both revenue and EBITDA figures and growth rates

Earnings quality

What changed since the last call

Deltas vs. the prior call

EBITDA margin guidance credibility

Downgrade

Prior 7-8% target; Q1 delivered 5.4%. Management now says recovery from Q2. Guidance track record weakened by 280 bps miss

India standalone growth trajectory

Downgrade

Core India DDL procurement only 3% YoY (ex-OSAM). Prior implied 8-10%. Slowdown driven by pricing strategy (not expanding in high-price geographies like Andhra)

Margin recovery timeline

Neutral

Still expect 7-8% by EoFY27, but now emphasize gradual pass-through from Q2. Q1 miss pushed recovery date out by 1 quarter

Africa & VAP outlook

Upgrade

Procurement network quality

Neutral

Emphasize Maharashtra +10%, but India overall 3% and selective growth (not expanding in Andhra due to competitive pricing). Supplier relationships strong but geog expansion cautious

The Q&A

Analysts pressed hard on three fronts: (1) Core India growth slowdown (Praveen Kumar, ICICI, others noted only 3% ex-OSAM vs prior 8-9%); (2) Timing of margin recovery (Aniruddha Joshi asked 'is worst behind?', management hedged); (3) Procurement data clarity (analyst forced management to break down OSAM, Africa, India separately; revealed India nearly flat). Management held up on Africa growth & VAP, but conceded pricing lagged cost inflation. Tone defensive but not evasive.

The exchanges that mattered

Margin trajectory — Praveen Kumar, Equitas Capital

Partial

Confident 7-8% EBITDA maintained despite cyclical pressure; seasonal, not structural reset. Price pass-through underway

Procurement growth ex-OSAM — Praveen Kumar, Equitas Capital

Answered

Andhra, Karnataka maintained (not degrowthing) but not expanding due to high competitive pricing; strategy is selective. Maharashtra +10%, Africa +28%

Margin recovery credibility — Aniruddha Joshi, ICICI Securities

Partial

Africa & Orga done 70-80% already. Dodla still catching up; took ₹1+ hike in May, ₹2 more in July, plan 2.5% in Q2. Most corrections done

Ice cream capex appetite — Aniruddha Joshi, ICICI Securities

Answered

No major expansion planned; growing from ₹16 Cr to ₹22 Cr Q1 on existing capacity. Wait & see this year; plan later

Milk price hike quantum — Darshita Shah, DSP Asset Managers

Answered

Plan 2-2.5% more in Q2, targeting 4-5% for full year on milk. Blended (VAP) will be higher

Volume growth resilience — Darshita Shah, DSP Asset Managers

Answered

Yes, target maintained 8-10% volume growth; pricing passed gradually, so growth continues

Competitive pricing landscape — Yash Goenka, Awriga Capital

Answered

Amul, Nandini taken ghee/milk hikes. National cooperatives will follow. TN gap ₹10+, KA gap ₹6-7. We took ₹2 avg across regions

Procurement cost normalization — Abhishek Mathur, Systematix Group

Partial

Normalization = no decline expected, just stabilization at ₹41/liter. May-June-July all flat around ₹41.20. No seasonal drop yet

Milk sales volume slowdown — Aditya, Securities Investment Management

Partial

Summer months, milk demand lower (shift to VAP). Africa milk +33% YoY. India milk 10.4L (seasonal). Normal trend resuming Q2

Execution priorities Q2+ — Sucrit Patil, EyeSight Fintrade

Partial

Africa on track to hit 100% targets (volume & EBITDA). Feed 25%+ growth. DDL already corrected pricing from mid-July. El-Niño weather impact, but no structural inventory issue

Portfolio composition 3-year outlook — Abhishek Kanithi, Nivaka Ventures

Answered

Africa stays ~10% (won't surge further without acquisitions). VAP: maintain 10% volume growth targeting; DDL 70-80%, overseas 15%, OSAM 8-10%

India core market growth headwinds — Bhavesh Jain, DD Investment Advisors

Answered

Core markets: maintain share, not push given high cooperatives gaps (TN, KA). Maharashtra milk balancing only 2L local sales. Geographic rotation strategy. 10% blended target

Direct farmer payment & productivity — Manish Jain, GormalOne LLP

Answered

100% direct farmer payment (nearly). Animal data hard to track; farmer avg increasing steadily. Dodla feed users do 14L vs non-users 11L per farmer

Guidance

Forward guidance and management's confidence

FY27 consolidated 15% revenue growth (10% volume + 5% pricing/mix)

Medium

Assumes continued India momentum + Africa scaling. Price hikes 4-5% target achievable but dependent on competitive landscape & demand elasticity

EBITDA 7-8% range FY27; recovery from Q2 onwards after Q1 cyclical 5.4%

Medium

Gradual pass-through of ₹2-2.5% milk + 3-4% VAP hikes Q2-Q3 expected to recover margin. Assumes procurement stabilizes at current ₹41/L

₹590 Cr capex (Maharashtra Greenfield, OSAM scale, Africa expansion) funded from internal accruals

High

No leverage needed; ₹689 Cr cash sufficient. Maharashtra on timeline, Kenya utilization ramping 80%, Uganda full capacity planned Greenfield

Risks the call surfaced

Ranked by how much they should concern a holder

Pricing power erosion

Medium

Dodla's ₹10+ price gap in TN, ₹6-7 in KA vs cooperatives will narrow if Amul/Mother Dairy take hikes. Current 4-5% FY27 hike plan may face volume pushback

Procurement cost persistence

High

Milk procurement costs elevated at ₹41.3/L vs ₹37.4/L prior year. Management expects normalization but says May-June-July all flat ~₹41.20/L. If monsoon disruption continues, prices stay high, margin recovery delayed

Core India DDL growth stalling

Medium

India DDL standalone milk procurement only 3% YoY (ex-OSAM). Analysts noted growth has slowed from prior 8-9%. Geographic expansion constrained by high cooperatives pricing (TN, KA) and selective capacity strategy

Margin miss credibility

High

Q1 EBITDA margin 5.4% vs 7-8% prior guidance (280 bps miss). Management blamed cyclical/seasonal pressure and pricing lag, but recovery now pushed to Q2+. If Q2 misses again, credibility erodes; investor sentiment on margin recovery guidance would deteriorate

Working capital inventory risk

Low

If procurement costs stay elevated and milk supply remains muted (not flushing), company may need to build inventory or become net buyer at high prices, stressing working capital. However, ₹689 Cr cash provides buffer

Management

Score 6/10. Transparent on numbers but narrative tries to minimize margin miss. Admitted pricing lag but framed as strategy (gradual pass-through vs lump-sum hikes). Candid on geographic constraints (high pricing in TN/KA limits expansion). Some NDA shielding on Sids Farm investment rationale (vague 'learning' language) Mixed. Hit revenue growth targets (+19% YoY on track for 15% guidance) but MISSED EBITDA margin target materially (5.4% vs 7-8%, 280 bps shortfall). Pricing lag relative to procurement inflation (₹2.2 vs ₹3.9 hike) indicates reactive vs proactive execution. However, Africa & VAP delivering well

What to watch next
  • 1 · Q2 FY27 (Aug-Sep)

    Price hike pass-through completion; procurement cost normalization post-monsoon

  • 2 · Q2 FY27 onwards

    Maharashtra Greenfield capex ramp; East India capacity/Chandel production shift

  • 3 · H2 FY27

    OSAM profitability inflection; Kenya processing capacity utilization towards 100%

Margin recovery depends entirely on successful price pass-through from Q2 onwards, which remains unproven as of call date (late July).

Informational and educational content only. Not investment advice.